Pharmaceutical Industry Information Portal

Moderna aims to roll out a combined flu and COVID vaccine in 2023

The biotechnological company Moderna is working to create a single shot vaccine against both flu and coronavirus by autumn 2023, Moderna’s Chief Executive Officer Stephane Bancel said at the World Economic Forum on 17 January 2022.

Moderna announced last September that it was working on a single component vaccine shot, capable of protecting against both flu and COVID-19.

Bancel said:

The best case scenario will be the fall of 2023.

Our goal is to be able to have a single annual booster so that we don’t have compliance issues where people don’t want to get to get two to three shots a winter, but to get one dose where they get a booster for Corona and a booster for flu and RSV to make sure people get their vaccines

The vaccine is expected to be approved in some countries by that time, according to Bancel. Moderna’s two component vaccine is now approved in the United States and widely exported all over the world.


Expert Articles